Search for: "MYLAN PHARMACEUTICALS INC"
Results 461 - 480
of 498
Sorted by Relevance
|
Sort by Date
12 May 2015, 2:43 pm
Steel Corp. 06366QH75 Bank of Montreal Reverse Exchangeable Notes linked to Alcoa, Inc. 06366QH91 Bank of Montreal Reverse Exchangeable Notes linked to Delta Air Lines, Inc. 06366QJ24 Bank of Montreal Reverse Exchangeable Notes linked to Dow Chemical Company 06366QJ73 Bank of Montreal Reverse Exchangeable Notes linked to Las Vegas Sands Corp. 06366QJ81 Bank of Montreal Reverse Exchangeable Notes linked to MercadoLibre Inc 06366QJ99 Bank of Montreal Reverse Exchangeable… [read post]
31 Jan 2014, 7:26 am
Mylan, Inc., No. 12-2502, 2013 U.S. [read post]
4 May 2011, 7:52 am
Generic Opioid Products Generic Name Drug Name Applicant/Sponsors Fentanyl Fentanyl Extended Release Transdermal System Actavis Fentanyl Fentanyl Extended Release Transdermal System Lavipharm Labs Fentanyl Fentanyl Extended Release Transdermal System Mylan Technologies Fentanyl Fentanyl Extended Release Transdermal System Teva Pharms Fentanyl Fentanyl Extended Release Transdermal System Watson … [read post]
8 Aug 2018, 11:15 pm
Mylan Pharmaceuticals, Inc. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
23 Aug 2011, 7:27 am
Mylan, Inc., 2011 U.S. [read post]
25 Mar 2011, 8:29 pm
Mylan Labs., Inc., 464 F.3d 1286, 1295 (Fed. [read post]
6 Aug 2011, 2:27 pm
.'s policy with Warren Funeral Chapel Inc. covered emotional distress under its definition of bodily injury. [read post]
28 Oct 2011, 7:00 am
Mylan Pharmaceuticals, Inc., 751 F. [read post]
15 Apr 2011, 6:02 am
Mylan Pharmaceuticals, Inc., 2009 WL 7115134, at *2 (N.D. [read post]
6 Jun 2008, 6:49 am
: (Spicy IP) Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
14 Mar 2011, 8:12 pm
(forthcoming)Motion for leave to file out of time amicus brief of American Bankers AssociationPetitioner's reply Title: Mylan Inc. v. [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
2 Feb 2012, 8:53 pm
Mylan Pharmaceuticals (phenytoin) Deposition2009-10-06 In re Trasylol PLL Deposition2009-10-06 Kendall v. [read post]
11 Jul 2008, 4:30 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
2 Aug 2008, 12:54 am
, (Daily Dose of IP), 20 August – Bill Patry Copyright Blog speaking on copyright – Melbourne: (Patry Copyright Blog), (LawFont.com), 21 August – Bill Patry Copyright Blog speaking on copyright – Canberra: (Patry Copyright Blog), (LawFont.com), 22 August – Bill Patry Copyright Blog speaking on copyright – Sydney: (Patry Copyright Blog), (LawFont.com), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat),… [read post]
11 Mar 2019, 7:08 pm
The asymmetry of this burden is especially salient in domains like pharmaceutical drugs and biosimilars, where the incentive to test the validity of patents has important social consequences, and the complexities of those decades-long disputes create fact patterns that can be difficult to unpack. [read post]
31 Mar 2010, 1:58 pm
Prods., Inc. v. [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
